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The human immune system can be divided into two major systems: the adaptive and the innate immune
systems. Adaptive immune responses are highly specific and are essential for control and elimination of
pathogens following infection. However, the response requires several days to occur. The innate immune
system functions to prevent the establishment of infection prior to the initiation of adaptive immune
responses. This response is immediate, directed against broad classes of pathogens rather than a specific
organism, and is usually sufficient to prevent establishment of infection. In addition, the innate immune
system is able to direct and shape adaptive immune responses against invading pathogens. Mucosal
tissues lining the body cavities, such as the respiratory tract, the gastrointestinal tract, or the reproductive
tract, are primary contact sites for invading pathogens. These surfaces are composed of epithelial cells that
act as a barrier to pathogen entry into the body and alert the immune system to the presence of an invading
pathogen by initiating innate immune responses to pathogen. The human reproductive tract is exposed to a
variety of sexually transmitted pathogens including Human Immunodeficiency Virus (HIV), Herpes Simplex
Virus (HSV), and Human Papilloma Virus (HPV). These viruses are the cause of vast global human health
and reproductive problems. Currently, there is a need to develop vaccines and treatment strategies to
prevent transmission of these viruses. This study examines a cellular protein known as Toll-like receptor 3
(TLR3) that is involved in detecting viral pathogens and initiating innate antiviral immune responses to
these viral pathogens. We have found that TLR3 is expressed by endometrial epithelial cells in the human
uterus, and that expression levels fluctuate with progression through the menstrual cycle. TLR3 expression
peaked during the secretory phase of the menstrual cycle, when the uterus is undergoing changes to
prepare for embryo implantation, and was dramatically decreased during menstruation until ovulation, when
TLR3 expression levels again begin to increase. Due to the cyclic nature of TLR3 expression, we
postulated that TLR3 expression was controlled by the endometrial steroid hormones, estrogen (E2) and
progesterone (P4).  Our results demonstrate that although TLR3 expression is not directly controlled by E2
and P4, the immune responses initiated upon recognition of viral infection by TLR3 are controlled by E2
and P4.  These data indicate that antiviral responses in the human uterus can be mediated by TLR3 and
can be controlled by fluctuating levels of E2 and P4 throughout the menstrual cycle, indicating that
susceptibility to viral infection may be altered at different stages of the menstrual cycle. These results
suggest that TLR3 ligands may be utilized in development of treatment and vaccine strategies against viral
pathogens of the reproductive tract. 
